Relevance of recruitment-synchronization in the scheduling of 1-beta-D-arabinofuranosylcytosine in a slow-growing acute myeloid leukemia of the rat
Aglietta, M.; Colly, L.
Cancer Research 39(7 Part 1): 2727-2732
1979
ISSN/ISBN: 0008-5472 PMID: 286639 Document Number: 147724
Document emailed within 1 workday
Related Documents
Nara, N.; Yamashita, Y.; Murohashi, I.; Tanikawa, S.; Imai, Y.; Aoki, N. 1987: Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin Cancer Research 47(9): 2376-2379Kharbanda, S.; Emoto, Y.; Kisaki, H.; Saleem, A.; Kufe, D. 1994: 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells Molecular Pharmacology 46(1): 67-72
Yamada, K.; Suzuki, H.; Kato, Y. 1980: Phase IIi study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(6): 1080-1085
TAnaka, M.; Yoshida, S. 1982: Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia Cancer Research 42(2): 649-653
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Caron, N.; Lee, S.H.; Kimball, A.P. 1977: Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210 Cancer Research 37(9): 3274-3279
Oh-ishi, J.; Kataoka, T.; Tsukagoshi, S.; Sakurai, Y.; Shibukawa, M.; Kobayashi, H. 1981: Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance Cancer Research 41(6): 2501-2506
Maehara, Y.; Kusumoto, T.; Sakaguchi, Y.; Kusumoto, H.; Anai, H.; Sugimachi, K. 1989: Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in Hela cells Anticancer Research 9(1): 41-44
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Morikawa, J.; Li, H.; Kim, S.; Nishi, K.; Ueno, S.; Suh, E.; Dougherty, E.; Shmulevich, I.; Shiku, H.; Zhang, W.; Kobayashi, T. 2003: Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha) International Journal of Oncology 23(3): 617-625
Bakhudze, E.V.; Evstigneeva, L.A.; Leenman, E.E.; Klimashevskiĭ, V.F.; Morozova, E.V.; Shashkova, N.G. 2006: Myeloid sarcoma of the uterine cervix as presentation of acute myeloid leukemia Voprosy Onkologii 52(1): 102-104
Promsuwicha, O.; Auewarakul, C.U. 2009: Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations Asian Pacific Journal of Allergy and Immunology 27(4): 209-216
Ludescher, C.; Eisterer, W.; Hilbe, W.; Gotwald, M.; Hofmann, J.; Zabernigg, A.; Cianfriglia, M.; Thaler, J. 1995: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia Leukemia 9(2): 350-356
Schrecker, A.W.; Smith, R.G.; Gallo, R.C. 1974: Comparative inhibition of purified DNA polymerases from murine leukemia virus and human lymphocytes by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate Cancer Research 34(2): 286-292
Grant, S.; Rauscher, F.; Cadman, E. 1982: Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors Cancer Research 42(10): 4007-4013
Tanaka, T.; Tanaka, K.; Ogawa, S.; Kurokawa, M.; Mitani, K.; Nishida, J.; Shibata, Y.; Yazaki, Y.; Hirai, H. 1995: An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms EMBO Journal 14(2): 341-350